Screener
Immunome IMNM Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Immunome’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344636
FAQ
- What is Immunome's operating lease liabilities (current)?
- Immunome (IMNM) reported operating lease liabilities (current) of $152K in Q2 2026.
- What is the long-term trend for Immunome's operating lease liabilities (current)?
- Over 3 years (2021 to 2025), Immunome's operating lease liabilities (current) has grown at a -100.0% compound annual growth rate (CAGR), from $500K to $0.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Immunome's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude